As research continues, we will learn more about how semaglutide affects ovarian function and whether it should be recommended for women with ovarian cysts
Further restrictions may be established through quantity limits, imposing constraints on the dosage and duration of usage
Selected References: Meissner WG, Remy P, Giordana C, Maltte D, Derkinderen P, Houto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrire N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O
(2020) presented convincing evidence that elevated TMAO in CVDs could result from the disease-related imbalance in gut microbiota but not the cause of CVDs ( In addition, TMA, the precursor of TMAO on human health and disease, has gained poor attention compared to TMAO